Market Access Medicare weight loss drug pilot on ice as insurers decline to contribute Pharmaceutical TechnologyThe US Government will now pick up the cost of weight loss drugs offered through the Medicare GLP-1 Bridge scheme until 31 December 2027.Market AccessMetabolic & GLP-1Read full story pharminent April 22, 2026 (Last updated: April 23, 2026) Pharmaceutical Technology The US Government will now pick up the cost of weight loss drugs offered through the Medicare GLP-1 Bridge scheme until 31 December 2027. Market AccessMetabolic & GLP-1Read full story Post navigation Previous: Revolution drug shows promise in early pancreatic cancerNext: FDA Releases Congressional Justification for FY 2027 Budget, Including Proposal Regarding Interchangeability of Biosimilars Related Stories Market Access How cost and perception could reshape the GLP-1 market pharminent August 21, 2026 Market Access D.C. Circuit Affirms HHS Authority Over 340B Rebate Models pharminent July 24, 2026 Market Access NICE aims to cut funding for Amgen lung cancer drug Lumykras pharminent July 9, 2026
